Midwest Trust Co Invests $452,000 in iShares Biotechnology ETF $IBB

Midwest Trust Co bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the second quarter, HoldingsChannel reports. The firm bought 3,570 shares of the financial services provider’s stock, valued at approximately $452,000.

Several other large investors have also modified their holdings of IBB. Ramirez Asset Management Inc. bought a new stake in iShares Biotechnology ETF in the first quarter valued at about $26,000. Berkshire Money Management Inc. bought a new position in iShares Biotechnology ETF during the 2nd quarter worth approximately $28,000. Harbor Asset Planning Inc. acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $31,000. Trust Co. of Toledo NA OH acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $32,000. Finally, Security National Bank bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $38,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $164.96 on Thursday. The stock’s 50 day simple moving average is $150.12 and its 200 day simple moving average is $136.49. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $165.81.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.